Poulikakos Dimitrios, Banerjee Debasish, Malik Marek
Cardiovascular Sciences Research Centre, St. George's University of London, London, UK; Renal and Transplantation Unit, St. George's Hospital NHS Trust, London, UK.
J Cardiovasc Electrophysiol. 2014 Feb;25(2):222-31. doi: 10.1111/jce.12328. Epub 2013 Dec 16.
The review discusses the epidemiology and the possible underlying mechanisms of sudden cardiac death (SCD) in chronic kidney disease (CKD), and highlights the unmet clinical need for noninvasive risk stratification strategies in these patients. Although renal dysfunction shares common risk factors and often coexists with atherosclerotic cardiovascular disease, the presence of renal impairment increases the risk of arrhythmic complications to an extent that cannot be explained by the severity of the atherosclerotic process. Renal impairment is an independent risk factor for SCD from the early stages of CKD; the risk increases as renal function declines and reaches very high levels in patients with end-stage renal disease on dialysis. Autonomic imbalance, uremic cardiomyopathy, and electrolyte disturbances likely play a role in increasing the arrhythmic risk and can be potential targets for treatment. Cardioverter defibrillator treatment could be offered as lifesaving treatment in selected patients, although selection strategies for this treatment mode are presently problematic in dialyzed patients. The review also examines the current experience with risk stratification tools in renal patients and suggests that noninvasive electrophysiological testing during dialysis may be of clinical value as it provides the necessary standardized environment for reproducible measurements for risk stratification purposes.
本综述讨论了慢性肾脏病(CKD)中心脏性猝死(SCD)的流行病学及可能的潜在机制,并强调了这些患者对无创风险分层策略尚未满足的临床需求。尽管肾功能不全与常见危险因素相关,且常与动脉粥样硬化性心血管疾病并存,但肾功能损害会增加心律失常并发症的风险,其程度无法用动脉粥样硬化进程的严重程度来解释。肾功能损害是CKD早期SCD的独立危险因素;随着肾功能下降,风险增加,在接受透析的终末期肾病患者中风险达到非常高的水平。自主神经失衡、尿毒症性心肌病和电解质紊乱可能在增加心律失常风险中起作用,并且可能成为治疗的潜在靶点。心脏复律除颤器治疗可作为选定患者的挽救生命的治疗方法,尽管目前这种治疗模式在透析患者中的选择策略存在问题。本综述还研究了目前在肾病患者中使用风险分层工具的经验,并表明透析期间的无创电生理检查可能具有临床价值,因为它为风险分层目的的可重复测量提供了必要的标准化环境。